How Northeastern Researchers are Transforming Cancer Immunotherapy

[00:00:00]What if cancer [music] treatment didn't have to mean constant hospital visits and overwhelming side effects? Today's immunotherapies often flood the [music] body with powerful drugs, causing inflammatory responses and forcing patients into repeated injections and frequent clinic visits. At Northeastern University, Srinivas [music] Sridhar is developing a new approach to sustained immunotherapy using biodegradable implants and targeted lipid nanoparticles. This technology [music] delivers low-dose immunomodulatory treatments continuously over days or even weeks. Instead of short bursts of treatment, this system provides controlled activation directly at the disease site, [music] reducing toxicity while improving consistency. From solid tumors to metastatic cancer and autoimmune diseases, this platform could transform how immunotherapies are delivered. [music] Fewer injections, smarter targeting, continuous care, a new future [music] for immunotherapy built at Northeastern University.